Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-((3s,3as)-3-cyclopentyl-7-(4-hydroxypiperidine-1-carbonyl)-3,3a,4,5-tetrahydropyrazolo(3,4-f)quinolin-2-yl)-2-chlorobenzonitrile
2. Kbp-5074
1. Ocedurenone [inn]
2. Kbp5074
3. Kbp-5074
4. L46509378r
5. 1359969-24-6
6. 2-chloro-4-((3s,3ar)-3-cyclopentyl-7-((4-hydroxy-1-piperidinyl)carbonyl)-3,3a,4,5-tetrahydro-2h-pyrazolo(3,4-f)quinolin-2-yl)benzonitrile
7. Benzonitrile, 2-chloro-4-((3s,3ar)-3-cyclopentyl-3,3a,4,5-tetrahydro-7-((4-hydroxy-1-piperidinyl)carbonyl)-2h-pyrazolo(3,4-f)quinolin-2-yl)-
8. Schembl15048760
9. Gtpl12040
10. Unii-l46509378r
11. Example 12 [us9468635b2]
12. Hy-132827
13. Cs-0204111
14. 4-[(3s,3ar)-3-cyclopentyl-7-(4-hydroxypiperidine-1-carbonyl)-3,3a,4,5-tetrahydropyrazolo[3,4-f]quinolin-2-yl]-2-chlorobenzonitrile
| Molecular Weight | 504.0 g/mol |
|---|---|
| Molecular Formula | C28H30ClN5O2 |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 92.8 |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 905 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Ocedurenone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ocedurenone, including repackagers and relabelers. The FDA regulates Ocedurenone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ocedurenone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ocedurenone supplier is an individual or a company that provides Ocedurenone active pharmaceutical ingredient (API) or Ocedurenone finished formulations upon request. The Ocedurenone suppliers may include Ocedurenone API manufacturers, exporters, distributors and traders.
Ocedurenone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ocedurenone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ocedurenone GMP manufacturer or Ocedurenone GMP API supplier for your needs.
A Ocedurenone CoA (Certificate of Analysis) is a formal document that attests to Ocedurenone's compliance with Ocedurenone specifications and serves as a tool for batch-level quality control.
Ocedurenone CoA mostly includes findings from lab analyses of a specific batch. For each Ocedurenone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ocedurenone may be tested according to a variety of international standards, such as European Pharmacopoeia (Ocedurenone EP), Ocedurenone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ocedurenone USP).
LOOKING FOR A SUPPLIER?
